About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.52 (-12.80%)
NERV NASDAQ Minerva Neurosciences Inc
Minerva Neurosciences Inc share price
NERV price activity
Last Price
$2.520
Change (24hr)
-0.37 USD (-12.80%)
Volume
123.43K
Volume (4w avg)
-
Open
$2.88
Day Range
$2.51 - $2.94
Previous Close
$2.89
Last Trade
13 Oct, 6:32 pm GMT+0
Delayed
13 Oct, 6:32 pm GMT+0
NERV price performance
Delayed
13 Oct, 6:32 pm GMT+0
NERV Market Signals